JO
TNXP icon

John Overdeck’s Tonix Pharmaceuticals TNXP Stock Holding History

John Overdeck’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Buy
+28,812
New +$372K ﹤0.01% 4383
2025
Q1 		– Sell
-2,008
Closed -$66.2K – 3490
2024
Q4 		$66.2K Buy
+2,008
New +$41.7K ﹤0.01% 3018
2023
Q3 		– Sell
-4
Closed -$20.1K – 3219
2023
Q2 		$20.1K Buy
4
+1
+33% +$7.58K ﹤0.01% 2906
2023
Q1 		$35.6K Buy
3
+2
+200% +$34.3K ﹤0.01% 2797
2022
Q4 		$8.26K Sell
1
-9
-90% -$77.7K ﹤0.01% 2738
2022
Q3 		$108K Buy
+10
New +$245K ﹤0.01% 2221
2021
Q4 		– Hold
0
– -$13K – 4897
2021
Q3 		– Hold
0
– – – 4173
2018
Q4 		– Hold
0
– -$14K – 3525
2018
Q3 		– Hold
0
– – – 3116

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

John Overdeck's TNXP Position: Q2 2026 in Review

John Overdeck opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 28,812 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #4383 among its holdings. This is a return to the name: John Overdeck previously reported a position in TNXP as recently as Q4 2024.

John Overdeck first reported a position in TNXP in Q3 2022 and has held it in 6 quarters since. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • John Overdeck held 28,812 shares of Tonix Pharmaceuticals worth $368K as of Q2 2026.
  • Tonix Pharmaceuticals was a new John Overdeck position in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4383 holding.
  • John Overdeck first reported a position in Tonix Pharmaceuticals in Q3 2022 and has held it in 6 quarters since.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.